pharma
dog
News
when
Latest
Archive
by source
All Sources
Sources Page
Jobs
department
Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access
therapeutic area
Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease
location & type
Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →
Drugs
by stage
Marketed
Phase 3
Phase 2
Phase 1
Preclinical
browse
Most catalysts
Recently active
All drugs →
Companies
Patent cliff
Calendar
what
Trial readouts
PDUFA dates
Approvals
Earnings
when
Upcoming
Month grid
Recently passed
◐
Sign In
Subscribe
home
jobs
news
search
Approval · news · pharmadog
← back to Approval
News · Approval
1,551
stories
2d
CTAD 2026: Biogen, AriBio lead the way in slowing cognitive decline in Alzheimer’s
biospace
2d
Merck scraps centerpiece of $2.7B ArQule buy after late-stage safety concerns
biospace
2d
STAT+: FDA discloses reasons for rejecting Summit drug
stat
2d
STAT+: Pharmalittle: We’re reading about Overton FDA nomination being yanked, a Merck setback, and more
stat
2d
FDA publishes rejection letter for Summit drug; Nuvalent buyout pays more dividends for GSK
biopharma dive
2d
GSK nabs FDA greenlight for second lung cancer asset from Nuvalent buy
biospace
2d
Summit’s rejection letter reveals FDA’s deeper concerns about trial design, safety
biospace
2d
Summit’s rejection, Isomorphic’s record $5B raise, obesity and Alzheimer’s in the spotlight
biospace
3d
Pfizer enters in vivo CAR-T space via 3-program, $2.6B deal with China’s Starna
fiercebiotech
3d
Less than a year into the job, Everett Cunningham steps down as Quanterix CEO
fiercebiotech
3d
5 acquisitions that forced Big Pharmas to co-parent
biospace
3d
Priavoid’s Alzheimer’s pill fails to prove efficacy in phase 2 trial
fiercebiotech
3d
FDA clears MiniMed Fit tubeless insulin pump
fiercebiotech
3d
Merck axes $2.7B BTK inhibitor program after seeing phase 3 data
fiercebiotech
3d
FDA Launches the Global Reliance Disclosure Program to Expand Patient Access to Medicines Worldwide
fda press
3d
Beren wins FDA approval for long-studied rare disease drug
endpoints
3d
GSK’s Nuvalent buyout delivers again as FDA clears Nelkarmi for lung cancer
endpoints
3d
FDA Approves First Drug Shown to Help Patients with Infantile-Onset Niemann-Pick Disease Type C Live Longer
fda press
3d
Sellas claims Phase 3 win on AML cancer vaccine
endpoints
3d
Roche breast cancer pill cleared by FDA
biopharma dive
3d
FDA’s complete response letter for Summit’s ivonescimab cites China-heavy data beyond survival miss
fiercebiotech
3d
Vertex on the verge of ‘iconic’ evolution as key kidney disease verdict looms
biospace
3d
Novo revamps its direct-to-consumer platform; Roche drug Gazyva approved again
endpoints
3d
STAT+: Pharmalittle: We’re reading about a Roche breast cancer pill, obesity drugs in children, and more
stat
3d
Sellas’ cancer vaccine slashes death risk by 41% in late-stage AML study
biospace
3d
Marrow raises $173M for siRNA drug competing with CRISPR therapy for sickle cell
endpoints
3d
Roche enters the SERD market with FDA approval in late-stage breast cancer
endpoints
4d
Flavored nicotine tablets, the tobacco industry’s latest product, worry public health advocates
stat
4d
STAT+: FDA approves new breast cancer drug, providing new option for some patients, boost for Roche
stat
4d
AstraZeneca, Alexion's myasthenia gravis treatment enters crowded market
endpoints
← prev
page 2 of 52
next →